FIELD: medicine.
SUBSTANCE: invention refers to medicine and concerns methods of treating tracheal, bronchial or alveolar haemorrhage or haemoptysis. Substance of the invention involves intratracheal, intrabronchial or intraalveolar introduction to a person of a blood-coagulation factor which is activated factor VII.
EFFECT: advantage of the invention consists in application of the blood-coagulation factor active at the earlier stages of the coagulation cascade.
16 cl, 1 ex
Authors
Dates
2010-08-10—Published
2005-09-09—Filed